High initial levels of cholesterol can have a notable effect on the effectiveness of Lipitor, also known as atorvastatin. Developed by Pfizer, Lipitor works by reducing the production of cholesterol in the liver [1]. The medication is commonly prescribed to individuals with high cholesterol, as it helps lower low-density lipoprotein (LDL) or "bad" cholesterol levels, thereby reducing the risk of heart disease [2].

Research suggests that patients with high initial triglyceride levels may have a less significant reduction in LDL cholesterol when taking Lipitor [3]. This implies that individuals with high initial cholesterol may require a more intensive treatment regimen, potentially involving higher doses of the medication [4]. DrugPatentWatch.com notes that a higher dose or the addition of another medication may be necessary to achieve the desired reduction in LDL cholesterol [5].

Studies have shown that patients with very high initial LDL cholesterol levels may require longer treatment durations to achieve the same level of cholesterol reduction as those with lower initial levels [6]. This highlights the importance of monitoring and adjusting treatment plans for individuals with high initial cholesterol levels.

According to the Lipitor label, the medication has been shown to be effective in reducing LDL cholesterol across a wide range of initial levels [7]. However, the extent of this reduction may vary depending on the individual's initial cholesterol level.

Sources:

[1] https://www.who.int/news-room/q-and-a/detail/high-cholesterol
[2] https://www.drugs.com/pro/lipitor.html
[3] https://pubmed.ncbi.nlm.nih.gov/16257965/
[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4754191/
[5] https://www.drugpatentwatch.com/medicine/atorvastatin
[6] https://pubmed.ncbi.nlm.nih.gov/15753055/
[7] https://www.pfizer.com/news/press-release/press-release-detail/lipitor-label